📊 AIFF Key Takeaways
Is Firefly Neuroscience, Inc.. (AIFF) a Good Investment?
Firefly Neuroscience is a severely distressed software company with catastrophic profitability metrics, burning substantial cash, and showing no revenue growth. The company is unprofitable at every level (gross profit exists but operating and net losses are massive), with negative free cash flow of $6.4M annually threatening long-term viability despite adequate liquidity.
Firefly Neuroscience shows very weak fundamentals: revenue is minimal and flat year over year, while operating and net losses are extraordinarily large relative to sales. Although the balance sheet is not heavily levered and near-term liquidity is still positive, current cash appears insufficient relative to ongoing cash burn, making the business highly dependent on external funding unless revenue scales materially.
Why Buy Firefly Neuroscience, Inc.. Stock? AIFF Key Strengths
- Positive gross margin of 63.4% indicates viable underlying unit economics at the product level
- Strong liquidity position with current ratio of 2.0x and $4.3M cash provides runway for operations
- Low leverage with debt-to-equity of 0.08x limits financial distress risk from creditors
- Gross margin of 63.4% suggests the core product can generate reasonable unit-level economics at current scale
- Balance sheet leverage is low, with debt/equity of 0.08x and limited long-term debt
- Current and quick ratios near 2.0x indicate acceptable short-term liquidity at the latest reporting date
AIFF Stock Risks: Firefly Neuroscience, Inc.. Investment Risks
- Revenue stagnation at $730K with zero YoY growth signals failed market traction and business model dysfunction
- Operating losses of $6.4M on revenue of $730K represent 870% negative operating margin, indicating massive overhead relative to sales
- Negative free cash flow of $6.4M annually will deplete $4.3M cash reserves within ~8 months at current burn rate, creating existential solvency risk
- Net losses of $17.4M (2,384% negative margin) suggest substantial non-operating charges or asset write-downs compounding operational problems
- Minimal insider activity (2 Form 4 filings in 90 days) suggests low management confidence or activity
- Revenue is only $730K and showed 0.0% YoY growth, indicating very weak commercial traction
- Operating loss of $6.36M and net loss of $17.40M versus tiny revenue reflect an unsustainable cost structure
- Operating cash flow of -$6.39M against $4.33M of cash implies funding risk and likely dilution or additional financing needs
Key Metrics to Watch
- Operating cash flow trend and runway to cash depletion at current burn rate
- Revenue growth rate - any stabilization or recovery from current stagnation
- Operating expense reduction and path to positive EBITDA
- Cash position and potential dilutive financing events
- Revenue growth and customer adoption
- Quarterly operating cash burn versus cash balance
Firefly Neuroscience, Inc.. (AIFF) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Firefly Neuroscience, Inc.. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
AIFF Profit Margin, ROE & Profitability Analysis
AIFF vs Technology Sector: How Firefly Neuroscience, Inc.. Compares
How Firefly Neuroscience, Inc.. compares to Technology sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Firefly Neuroscience, Inc.. Stock Overvalued? AIFF Valuation Analysis 2026
Based on fundamental analysis, Firefly Neuroscience, Inc.. has mixed fundamental signals relative to the Technology sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Firefly Neuroscience, Inc.. Balance Sheet: AIFF Debt, Cash & Liquidity
AIFF Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Firefly Neuroscience, Inc..'s revenue has declined by 92% over the 5-year period, indicating business contraction. The most recent EPS of $0.03 reflects profitable operations.
AIFF Revenue Growth, EPS Growth & YoY Performance
AIFF Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $33.0K | -$1.1M | $-0.20 |
| Q2 2025 | $10.0K | -$1.1M | N/A |
| Q1 2025 | $12.0K | -$1.1M | N/A |
| Q3 2024 | $23.0K | -$650.0K | N/A |
| Q2 2024 | $1.9M | $234.8K | $0.36 |
| Q1 2024 | $1.9M | -$674.0K | N/A |
| Q3 2023 | $2.0M | -$149.9K | N/A |
| Q2 2023 | $2.0M | $234.8K | $0.01 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Firefly Neuroscience, Inc.. Dividends, Buybacks & Capital Allocation
AIFF SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Firefly Neuroscience, Inc.. (CIK: 0000803578)
📋 Recent SEC Filings
❓ Frequently Asked Questions about AIFF
What is the AI rating for AIFF?
Firefly Neuroscience, Inc.. (AIFF) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 93% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are AIFF's key strengths?
Claude: Positive gross margin of 63.4% indicates viable underlying unit economics at the product level. Strong liquidity position with current ratio of 2.0x and $4.3M cash provides runway for operations. ChatGPT: Gross margin of 63.4% suggests the core product can generate reasonable unit-level economics at current scale. Balance sheet leverage is low, with debt/equity of 0.08x and limited long-term debt.
What are the risks of investing in AIFF?
Claude: Revenue stagnation at $730K with zero YoY growth signals failed market traction and business model dysfunction. Operating losses of $6.4M on revenue of $730K represent 870% negative operating margin, indicating massive overhead relative to sales. ChatGPT: Revenue is only $730K and showed 0.0% YoY growth, indicating very weak commercial traction. Operating loss of $6.36M and net loss of $17.40M versus tiny revenue reflect an unsustainable cost structure.
What is AIFF's revenue and growth?
Firefly Neuroscience, Inc.. reported revenue of $730.0K.
Does AIFF pay dividends?
Firefly Neuroscience, Inc.. does not currently pay dividends.
Where can I find AIFF SEC filings?
Official SEC filings for Firefly Neuroscience, Inc.. (CIK: 0000803578) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is AIFF's EPS?
Firefly Neuroscience, Inc.. has a diluted EPS of $-1.81.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is AIFF a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Firefly Neuroscience, Inc.. has a STRONG SELL rating with 93% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is AIFF stock overvalued or undervalued?
Valuation metrics for AIFF: ROE of -180.2% (sector avg: 22%), net margin of -2,383.8% (sector avg: 18%). Compare these metrics with sector averages to assess valuation.
Should I buy AIFF stock in 2026?
Our dual AI analysis gives Firefly Neuroscience, Inc.. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is AIFF's free cash flow?
Firefly Neuroscience, Inc..'s operating cash flow is $-6.4M, with capital expenditures of $0.0. FCF margin is -875.2%.
How does AIFF compare to other Technology stocks?
Vs Technology sector averages: Net margin -2,383.8% (avg: 18%), ROE -180.2% (avg: 22%), current ratio 2.00 (avg: 2.5).